A novel antineuronal antibody in stiff-man syndrome. uri icon

Overview

abstract

  • Two-thirds of stiff-man syndrome (SMS) patients harbor an autoantibody specific for a 64-kD species of glutamic acid decarboxylase (GAD), the rate-limiting enzyme in GABA synthesis. We assayed SMS antisera from two patients with SMS for the presence of anti-GAD antibodies using Western blot, immunohistochemical, and enzymatic analyses. Both SMS antisera recognized an 80-kD antigen present in human and rat neuronal extracts, and failed to recognize the 64-kD GAD species. Immunohistochemistry demonstrated neuronal binding identical to that reported with anti-GAD antibodies. Both sera depleted GAD activity from brain extracts. Our analysis indicates that these SMS antisera differ from previously reported SMS antisera by recognizing a novel 80-kD antigen, and suggests that they contain antibodies directed against either a species of GAD different in size from the 64-kD enzyme, or a protein that co-immunoprecipitates with GAD.

publication date

  • January 1, 1993

Research

keywords

  • Autoantibodies
  • Glutamate Decarboxylase
  • Stiff-Person Syndrome

Identity

Scopus Document Identifier

  • 0027470881

Digital Object Identifier (DOI)

  • 10.1212/wnl.43.1_part_1.114

PubMed ID

  • 8423873

Additional Document Info

volume

  • 43

issue

  • 1